Cargando…

Clinical Significance of Observation without Repeated Radioiodine Therapy in Differentiated Thyroid Carcinoma Patients with Positive Surveillance Whole-Body Scans and Negative Thyroglobulin

BACKGROUND/AIMS: Currently, there is no consensus on the necessity of repeated radioiodine therapy (RAI) in patients who show iodine uptake in the thyroid bed on a diagnostic whole-body scan (DxWBS) despite undetectable thyroglobulin (Tg) levels after remnant ablation. The present study investigated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Dong-Jun, O, Joo Hyun, Kim, Min-Hee, Kim, Ji-Hyun, Kwon, Hyuk-Sang, Kim, Sung-Hoon, Kang, Moo-Il, Cha, Bong-Yun, Lee, Kwang-Woo, Son, Ho-Young
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997970/ https://www.ncbi.nlm.nih.gov/pubmed/21179279 http://dx.doi.org/10.3904/kjim.2010.25.4.408

Ejemplares similares

Thyrotrophin receptors, tumour radioiodine concentration and thyroglobulin secretion in differentiated thyroid cancers.
por: Edmonds, C. J., et al.
Publicado: (1985)

Is There a Role for Unstimulated Thyroglobulin Velocity in Predicting Recurrence in Papillary Thyroid Carcinoma Patients with Detectable Thyroglobulin after Radioiodine Ablation?
por: Wong, Hilda, et al.
Publicado: (2012)

The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
por: Kim, Hee Kyung, et al.
Publicado: (2020)

Localization of thyroglobulin antigenicity in rat thyroid sections using antibodies labled with peroxidase or (125)I-radioiodine
por: Paiement, J, et al.
Publicado: (1977)

Predictive Value of Thyroglobulin Changes for the Curative Effect of Radioiodine Therapy in Patients With Metastatic Differentiated Thyroid Carcinoma
por: Wang, Congcong, et al.
Publicado: (2021)

Recombinant human TSH stimulated thyroglobulin levels at remnant ablation predict structural incomplete response to treatment in patients with differentiated thyroid cancer
por: Ha, Jeonghoon, et al.
Publicado: (2017)

Undetectable thyroglobulin makes (123)I whole-body scan and stimulated thyroglobulin obsolete in follow-up care of differentiated thyroid cancer: a retrospective study
por: Sol, Bastiaan, et al.
Publicado: (2021)

Early stimulated thyroglobulin for response prediction after recombinant human thyrotropin-aided radioiodine therapy
por: Park, Hee Jeong, et al.
Publicado: (2017)

Identification of Intermediate- to High-Risk Papillary Thyroid Carcinoma Patients Who May Be Safely Managed without the Performance of Delayed Stimulated Thyroglobulin Measurements following Total Thyroidectomy and Radioactive Iodine Therapy
por: Kim, Kyung-Hee, et al.
Publicado: (2015)

Serial stimulated thyroglobulin measurements are more specific for detecting distant metastatic differentiated thyroid cancer before radioiodine therapy
por: Zhao, Teng, et al.
Publicado: (2017)

A Case Report of Dramatically Increased Thyroglobulin after Lymph Node Biopsy in Thyroid Carcinoma after Total Thyroidectomy and Radioiodine
por: Moosavi, Mandana, et al.
Publicado: (2016)

Preoperative Serum Thyroglobulin and Its Correlation with the Burden and Extent of Differentiated Thyroid Cancer
por: Kim, Hosu, et al.
Publicado: (2020)

Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer
por: Giovanella, Luca, et al.
Publicado: (2023)

Incidental Spleen Cyst Mimicking Thyroid Carcinoma Metastasis: False-positive Uptake on Radioiodine Whole Body Scan
por: Genç, Mustafa, et al.
Publicado: (2023)

Preoperative serum thyroglobulin predicts initial distant metastasis in patients with differentiated thyroid cancer
por: Kim, Hosu, et al.
Publicado: (2017)

SAT551 Significantly Elevated Thyroglobulin Levels with Negative Whole-Body Scan and PET/CT After Treatment of Thyroid Cancer: A Case Report
por: Bassatne, Aya, et al.
Publicado: (2023)

Prognostic Significance of Thyroglobulin Antibodies in Differentiated Thyroid Cancer
por: Reverter, Jordi L., et al.
Publicado: (2020)

SAT546 Papillary Thyroid Cancer Surveillance: Thyroglobulin Levels Affected by HAMA
por: Perez, Julienne Sanchez, et al.
Publicado: (2023)

Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer
por: Choi, Yoon Ju, et al.
Publicado: (2021)

Is it possible to predict hypothyroidism after thyroid lobectomy through thyrotropin, thyroglobulin, anti-thyroglobulin, and anti-microsomal antibody?
por: Cho, Jin Seong, et al.
Publicado: (2011)

Role of Preablative Stimulated Thyroglobulin in Prediction of Nodal and Distant Metastasis on Iodine Whole-Body Scan
por: Prabhu, Meghana, et al.
Publicado: (2018)

Role of Preablative-Stimulated Thyroglobulin in Prediction of Nodal and Distant Metastasis on Iodine Whole-body Scan
por: Bothra, Sapana, et al.
Publicado: (2018)

The Role of Pre-ablative Stimulated Thyroglobulin and Thyroglobulin/ Thyroid-Stimulating Hormone Ratio for Predicting Metastasis in Thyroid Cancer
por: Demir, Fadime, et al.
Publicado: (2019)

Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis
por: Piscopo, Leandra, et al.
Publicado: (2023)

Do radioiodine-avid lymph nodes from differentiated thyroid cancer on the initial posttherapy scan need repeated (131)I therapy?
por: Jiang, Yongji, et al.
Publicado: (2023)

Optimization of Predictive Performance for the Therapeutic Response Using Iodine Scan-Corrected Serum Thyroglobulin in Patients with Differentiated Thyroid Carcinoma
por: Yoo, Su Woong, et al.
Publicado: (2020)

Lung nodule detected by F-18 fluorodeoxyglucose positron emission tomography-computed tomography in patients with papillary thyroid cancer, negative (131)I whole body scan, and undetectable serum-stimulated thyroglobulin levels: two case reports
por: Jung, Chan-Hee, et al.
Publicado: (2012)

OR11-1 Thyroglobulin Structural Requirements in Protein Trafficking for Thyroid Hormonogenesis
por: Arvan, Peter, et al.
Publicado: (2022)

Added Value of Postoperative Radioiodine Scan for Staging and Risk Stratification in Papillary Thyroid Microcarcinoma
por: Kaewchur, Tawika, et al.
Publicado: (2021)

Prognostic Value of Serum Thyroglobulin and Anti-Thyroglobulin Antibody in Thyroid Carcinoma Patients following Thyroidectomy
por: Zahra, Hashem O., et al.
Publicado: (2021)

Utility of (99m)Tc-Hynic-TOC in 131I Whole-Body Scan Negative Thyroid Cancer Patients with Elevated Serum Thyroglobulin Levels
por: Shinto, Ajit S., et al.
Publicado: (2015)

Can the basal serum thyroglobulin level be used to predict the recombinant human TSH-stimulated thyroglobulin level in differentiated patients with thyroid cancer?
por: Jeong, Eugene, et al.
Publicado: (2019)

Whole-Body Radioiodine Effective Half-Life in Patients with Differentiated Thyroid Cancer
por: Klain, Michele, et al.
Publicado: (2021)

Utility of Stimulated Thyroglobulin in the Differentiate Thyroid Cancer
por: Romero, Fabiola, et al.
Publicado: (2021)

Preliminary study on the efficacy of xerostomia treatment with sialocentesis targeting thyroid disease patients given radioiodine therapy
por: Kim, Euy-Hyun, et al.
Publicado: (2019)

FRTL-5 Rat Thyroid Cells Release Thyroglobulin Sequestered in Exosomes: A Possible Novel Mechanism for Thyroglobulin Processing in the Thyroid
por: Vlasov, Pavel, et al.
Publicado: (2016)

An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na(+)/I(−) Symporter Function in Radioiodine-Refractory Papillary Thyroid Cancer Cells
por: Singh, Thoudam Debraj, et al.
Publicado: (2023)

Value of (18)F-FDG Hybrid PET/MR in Differentiated Thyroid Cancer Patients with Negative (131)I Whole-Body Scan and Elevated Thyroglobulin Levels
por: Li, Hongyan, et al.
Publicado: (2021)

Impact of (18)F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative (131)I whole body scan and elevated serum thyroglobulin
por: Boktor, Raef R., et al.
Publicado: (2022)

Tenosynovial Giant Cell Tumor of Foot in a Patient with Radioiodine-Refractory Thyroid Cancer: Imaging Findings on FDG-PET/CT, MRI, and Radioiodine Scan
por: Loharkar, Sarvesh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3lhgnlabg59nvui2igjvct2hqn